Lilly, a global leader in innovative pharmaceutical products, today announced the launch its 'All Hands' project, a major national initiative aimed at raising broad awareness around diabetes detection and treatment among the country's public healthcare professionals and patients. The project, which will visit 29 governorates across Egypt and will run through the end of 2011, aims to provide 2-day educational workshops to 4,000 public healthcare professionals, educate 500,000 diabetes patients through 500 educators based in government clinics, and screen 500,000 suspected diabetes patients across the country.
"The 'All Hands' initiative was developed in cooperation with the Egyptian Ministry of Health and in response to a growing need for better informed and better trained public healthcare professionals with respect to diabetes," said Dr. Sherif Rashed, Egypt country manager at Lilly Egypt. "This initiative is unprecedented in size and in its targeted accomplishments, and is driven by Lilly's ongoing commitment to improve education and treatment across all areas of healthcare so that Egyptians can live longer, healthier and more active lives."
The 'All Hands' project has been developed with three key objectives, the first being skills development for 4,000 healthcare professionals in government clinics who are the first line of treatment for diabetics, and who will all receive training at workshops especially setup for the project. All trained healthcare professionals will also receive certification. The second objective is to reach 500,000 Egyptians through targeted education sessions being led by 500 educators who will be based throughout the public clinics across Egypt until the end of 2011. The third objective is to screen 500,000 Egyptians who potentially have diabetes to ensure that treatment is administered to them to prevent further decline of health. Lilly will be conducting these screenings at the public clinics and will be providing screening equipment including glucose meters and diabetes test strips used for determining the approximate concentration of glucose in the blood.
"We are proud to be working with the Ministry of health and the broader medical community to instill new levels of knowledge and skill among Egypt's healthcare professionals while we work to arrest the progression of diabetes in Egypt." said Rashed.
